Tirz GLP-1 / GIP

Starting at $129.00

Orders over $250 qualify for FREE standard shipping.

🔥 Mix & Match Research Bundle
✅ Add 3 items → Save 15%
✅ Add 5 items → Save 20%
✅ Add 7 items → Save 25%
Mix any research compounds. Discount applies automatically.
Technical Specifications

  • Purity: ≥99%

  • Testing Method: HPLC

  • Form: Lyophilized powder

  • Container: 3 mL sterile vial

  • Storage: Refrigerated (2–8°C)

  • Documentation: Batch COA available

✓ RUO   ✓ Batch Verified   ✓ COA Available   ✓ Secure Checkout

Regulatory Notice: Products are intended for laboratory research use only and are not approved for human or veterinary applications.

Description


Research Overview

Tirz is a dual GIP/GLP-1 receptor co-agonist — a class of incretin-based research compounds that simultaneously engage both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual receptor activity distinguishes it mechanistically from single-receptor GLP-1 agonists and has made it a significant subject of metabolic research.

As a 39-amino acid synthetic peptide engineered from a GIP peptide backbone, Tirz is studied in preclinical and clinical metabolic models for its role in glycemic regulation, energy homeostasis, and adipose tissue biology.

Explore related research in our Research Library


Scientific Background

Tirz achieves GIP receptor affinity comparable to native GIP while binding the GLP-1 receptor with approximately 5-fold weaker affinity than native GLP-1 — a pharmacological balance that appears to drive enhanced metabolic outcomes relative to selective GLP-1 agonism alone. Research has demonstrated that GIP and GLP-1 receptor co-activation produces synergistic effects on insulin secretion, appetite suppression, and body weight regulation.

The SURPASS clinical trial program, comprising five large-scale randomized controlled trials, has established Tirz as one of the most extensively characterized incretin compounds in metabolic research, with ongoing investigation expanding into cardiovascular outcomes, hepatic steatosis, and neurological applications.


Molecular Information

  • Peptide Type: Dual GIP/GLP-1 receptor co-agonist (“twincretin”)
  • Amino Acid Length: 39 amino acids (modified GIP backbone)
  • Primary Targets: GIP receptor and GLP-1 receptor (incretin signaling)
  • Research Classification: Dual incretin metabolic research compound
  • Purity: ≥99% (HPLC verified)
  • Appearance: Lyophilized powder
  • Storage: Refrigerated (2–8°C)

 


Quality & Analytical Standards

Each batch undergoes analytical verification to confirm identity and purity. Batch-specific Certificates of Analysis (COA) are maintained for all production runs and available upon request.


Research Use Only

This product is intended strictly for laboratory research purposes. Not approved for human or veterinary use. No therapeutic or diagnostic claims are made. BioStrata Research supplies materials exclusively for qualified research and analytical applications.

2 reviews for Tirz GLP-1 / GIP

  1. jonathon.king

    Great product, fast delivery, easy ordering process. I will use them again

  2. debbiemeshew

    This product works really well and fast. I recommend this product for weight loss.

Add a review

Your email address will not be published. Required fields are marked *

Get Your Free Peptide Research Guide + 15% Off

Join BioStrata to receive:

✓ Free Peptide Research Quick Reference Guide (instant download)
✓ Access to the full Biostrata Research Library
✓ Weekly peptide research news and regulatory updates
✓ 15% off your first order — Code: 15offnew
✓ Free shipping on orders over $250

Research Access Capture

Research Access Verification

By entering this website you confirm you are at least 21 years of age and acknowledge all products are strictly for laboratory research use only (RUO) and not intended for human or veterinary use.